Product Information
FENOFIBRIC ACID DR 45 MG CAP is a generic product labeled by Leading Pharma, LLC, priced at $0.1611 per EA under NDC 69315028109. Its NADAC has been published 227 times since Jun 1, 2022.
FDA first approved this application on Jul 18, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
45 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315028109
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FENOFIBRIC ACIDApproval Type
Generic (ANDA)
FDA Application
ANDA211626FDA Approved
7/18/2019
TE Code
AB
On Market Since
7/18/2019
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRIC ACID DR 45 MG CAP has been published 227 times since Jun 1, 2022, and over the history we have for it it has declined 43.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1611 per EA |
|---|---|
| All-time high | $0.3407 (Aug 10, 2022) |
| All-time low | $0.1018 (Nov 20, 2024) |
| 52-week high | $0.1611 |
| 52-week low | $0.1423 |
| Median price | $0.1583 |
| Average price | $0.1725 |
| Largest weekly change | +41.3% (Mar 22, 2023) |
| Weeks tracked | 227 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Leading Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
FENOFIBRIC ACID market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Peroxisome Proliferator Receptor alpha Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FENOFIBRIC ACID DR 45 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRIC ACID DR 45 MG CAP, manufactured by Leading Pharma, LLC, is $0.1611 per EA (NDC 69315028109), effective Sep 30, 2026.
How has the price of FENOFIBRIC ACID DR 45 MG CAP changed over time?
Over the history we have for it, the NADAC for FENOFIBRIC ACID DR 45 MG CAP has declined 43.9%. It has been tracked across 227 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for FENOFIBRIC ACID DR 45 MG CAP?
Since Jun 1, 2022, the NADAC for FENOFIBRIC ACID DR 45 MG CAP has ranged from a low of $0.1018 (Nov 20, 2024) to a high of $0.3407 (Aug 10, 2022), with a median of $0.1583 per EA.
Are there cheaper alternatives to FENOFIBRIC ACID DR 45 MG CAP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FENOFIBRIC ACID DR 45 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures FENOFIBRIC ACID DR 45 MG CAP?
FENOFIBRIC ACID DR 45 MG CAP (NDC 69315028109) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.